NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $41M
- YoY, 2025
- +23.7%
- 5-year CAGR
- +32.3%
- 10-year CAGR
- +28.1%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $41M | +23.7% |
| 2024 | $33M | +35.6% |
| 2023 | $25M | −0.2% |
| 2022 | $25M | +9.9% |
| 2021 | $22M | +119.9% |
| 2020 | $10M | +2.1% |
| 2019 | $10M | +43.8% |
| 2018 | $7.0M | +8.0% |
| 2017 | $6.4M | +18.4% |
| 2016 | $5.4M | +56.3% |
| 2015 | $3.5M | +442.7% |
| 2014 | $641K | −3.8% |
| 2013 | $666K | +3.3% |
| 2012 | $645K | +126.3% |
| 2011 | $285K | — |